Luminex Corporation · Austin, TX United States ·(NASDAQ (GM): LMNX)
Company Description
This link will open in a new window Luminex Corporation sheds new light on genetic mysteries. The company's xMAP technology -- which consists of instruments, software, and disposable microspheres, or tiny beads on which tests are performed -- allows users to run up to 100 bioassays on one drop of fluid. Luminex licenses the technology to other life sciences companies which develop reagent-based tests to go with the instrumentation systems and then distribute them to end users, or use them to perform testing services for their customers. Luminex also develops some assays of its own. Its strategic partners include companies focused on drug discovery and biomedical research (
Key Luminex Corporation Financials
| Company Type | Public - NASDAQ (GM): LMNX Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $104.4 |
| 2008 Employees | 384 |
Luminex Corporation Executives
| Title | Name & Bio | Contact |
| Chairman | G. Walter Loewenbaum | Network |
| President, CEO, and Director | Patrick Balthrop | Network |
| SVP Operations | Michael Pintek | Network |